These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35750199)

  • 1. Taming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy.
    Lei J; Yang Y; Lu Z; Pan H; Fang J; Jing B; Chen Y; Yin L
    Biochem Pharmacol; 2022 Aug; 202():115153. PubMed ID: 35750199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma.
    Conde E; Casares N; Mancheño U; Elizalde E; Vercher E; Capozzi R; Santamaria E; Rodriguez-Madoz JR; Prosper F; Lasarte JJ; Lozano T; Hervas-Stubbs S
    Mol Ther; 2023 Jan; 31(1):48-65. PubMed ID: 36045586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-Phenolic Nanomedicines Regulate T-Cell Antitumor Function for Sono-Metabolic Cancer Therapy.
    Yan J; Li W; Tian H; Li B; Yu X; Wang G; Sang W; Dai Y
    ACS Nano; 2023 Aug; 17(15):14667-14677. PubMed ID: 37486249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
    Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
    Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression.
    Andersen R; Borch TH; Draghi A; Gokuldass A; Rana MAH; Pedersen M; Nielsen M; Kongsted P; Kjeldsen JW; Westergaard MCW; Radic HD; Chamberlain CA; Hölmich LR; Hendel HW; Larsen MS; Met Ö; Svane IM; Donia M
    Ann Oncol; 2018 Jul; 29(7):1575-1581. PubMed ID: 29688262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.
    Kumagai S; Koyama S; Itahashi K; Tanegashima T; Lin YT; Togashi Y; Kamada T; Irie T; Okumura G; Kono H; Ito D; Fujii R; Watanabe S; Sai A; Fukuoka S; Sugiyama E; Watanabe G; Owari T; Nishinakamura H; Sugiyama D; Maeda Y; Kawazoe A; Yukami H; Chida K; Ohara Y; Yoshida T; Shinno Y; Takeyasu Y; Shirasawa M; Nakama K; Aokage K; Suzuki J; Ishii G; Kuwata T; Sakamoto N; Kawazu M; Ueno T; Mori T; Yamazaki N; Tsuboi M; Yatabe Y; Kinoshita T; Doi T; Shitara K; Mano H; Nishikawa H
    Cancer Cell; 2022 Feb; 40(2):201-218.e9. PubMed ID: 35090594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and antitumor immunity of CD8
    Liu Y; Wang F; Peng D; Zhang D; Liu L; Wei J; Yuan J; Zhao L; Jiang H; Zhang T; Li Y; Zhao C; He S; Wu J; Yan Y; Zhang P; Guo C; Zhang J; Li X; Gao H; Li K
    Sci Transl Med; 2024 Aug; 16(762):eadk7399. PubMed ID: 39196962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting metabolism to enhance immunotherapy within tumor microenvironment.
    Liang XH; Chen XY; Yan Y; Cheng AY; Lin JY; Jiang YX; Chen HZ; Jin JM; Luan X
    Acta Pharmacol Sin; 2024 Oct; 45(10):2011-2022. PubMed ID: 38811773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming.
    Yu T; Liu Z; Tao Q; Xu X; Li X; Li Y; Chen M; Liu R; Chen D; Wu M; Yu J
    Cancer Lett; 2024 May; 589():216824. PubMed ID: 38522774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Specific Peroxynitrite Overproduction Disrupts Metabolic Homeostasis for Sensitizing Melanoma Immunotherapy.
    Yang L; Wang D; Jia H; Yang C; Zhang Y; Li H; Liu J; Liu J
    Adv Mater; 2023 Jul; 35(29):e2301455. PubMed ID: 37133969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment.
    Qiao G; Chen M; Mohammadpour H; MacDonald CR; Bucsek MJ; Hylander BL; Barbi JJ; Repasky EA
    Cancer Immunol Res; 2021 Jun; 9(6):651-664. PubMed ID: 33762351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
    Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
    J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma.
    Najjar YG; Menk AV; Sander C; Rao U; Karunamurthy A; Bhatia R; Zhai S; Kirkwood JM; Delgoffe GM
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30721155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation.
    Beckermann KE; Hongo R; Ye X; Young K; Carbonell K; Healey DCC; Siska PJ; Barone S; Roe CE; Smith CC; Vincent BG; Mason FM; Irish JM; Rathmell WK; Rathmell JC
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8
    Cheng J; Yan J; Liu Y; Shi J; Wang H; Zhou H; Zhou Y; Zhang T; Zhao L; Meng X; Gong H; Zhang X; Zhu H; Jiang P
    Cell Metab; 2023 Jun; 35(6):961-978.e10. PubMed ID: 37178684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects on anaplerotic pathways alter the metabolic landscape in the tumor microenvironment, causing unpredictable, sustained anti-tumor immunity.
    Udono H; Nishida M
    Int Immunol; 2022 Feb; 34(3):133-140. PubMed ID: 34491338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity.
    Ohashi T; Akazawa T; Aoki M; Kuze B; Mizuta K; Ito Y; Inoue N
    Int J Cancer; 2013 Sep; 133(5):1107-18. PubMed ID: 23420584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Regulation of CD8
    Zheng Y; Wang X; Huang M
    Antioxid Redox Signal; 2022 Dec; 37(16-18):1234-1253. PubMed ID: 35345890
    [No Abstract]   [Full Text] [Related]  

  • 20. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.